Anzeige
Mehr »
Login
Samstag, 18.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Spezial Report: NASDAQ-FinTech mit 3.000% Wachstum und 500% Kurs-Chance!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 04.10.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
04.10.23Sigyn Therapeutics, Inc.: Sigyn Therapeutics Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity72SAN DIEGO, CA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a development-stage medical technology company, today disclosed...
► Artikel lesen
04.10.23Freeline Therapeutics Holdings plc: Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease194Robust increases of up to 700-fold over baseline in plasma GCase enzyme activity in first two patients treated with FLT201 Normalization of leukocyte GCase in both patients demonstrates cellular...
► Artikel lesen
04.10.23StoneCo Ltd.: StoneCo Announces Repurchase Program347GEORGETOWN, Grand Cayman, Oct. 03, 2023 (GLOBE NEWSWIRE) -- StoneCo Ltd. (Nasdaq: STNE; B3: STOC31) ("Stone" or the "Company") announced that its Board of Directors, pursuant to written resolutions...
► Artikel lesen
04.10.23Goodfellow Inc.: Goodfellow Reports Its Results for the Third Quarter Ended August 31, 2023 and Declares Dividend219DELSON, Quebec, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Goodfellow Inc. (TSX: GDL) (the "Company" or "Goodfellow") announced today its financial results for the third quarter of fiscal year 2023. For the...
► Artikel lesen
04.10.23Ocean Biomedical, Inc.: Updated: Ocean Biomedical Announces Non-Dilutive Amendment to Existing Agreement with Polar Multi-Strategy Master Fund250Providence, RI, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA) announces that the company and Polar Multi-Strategy Master Fund (Polar) entered into a Side Letter related to...
► Artikel lesen
04.10.23Riot Platforms, Inc.: Riot Announces September 2023 Production and Operations Updates537CASTLE ROCK, Colo., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) ("Riot" or "the Company"), an industry leader in Bitcoin ("BTC") mining and data center hosting, announces...
► Artikel lesen
04.10.23Nanobiotix S.A.: Nanobiotix Announces the Presentation of the Final Efficacy Analysis From Phase 1 Cohort Expansion Evaluating NBTXR3 in Locally Advanced Head and Neck Cancer Showing Median Progression-Free Survival of 16.9 Months and Median Overall Survi181Final data from Study 102 Dose Expansion show that radiotherapy-activated NBTXR3 was feasible and well tolerated in elderly patients with a high burden of comorbidity (n=56)Consistently high injected-lesion...
► Artikel lesen
04.10.23Agile Therapeutics, Inc.: Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)371PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the granting of a previously disclosed inducement award to...
► Artikel lesen
04.10.23Costco Wholesale Corporation Reports September Sales Results190ISSAQUAH, Wash., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation ("Costco" or the "Company") (Nasdaq: COST) today reported net sales of $22.75 billion for the retail month of September...
► Artikel lesen
04.10.23Home Plate Acquisition Corp: Heidmar Inc. Announces Termination of Merger Agreement115ATHENS, Greece, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Heidmar Inc. (the "Company") announced today that it has terminated the Business Combination Agreement dated March 19, 2023 (as amended, the "Business...
► Artikel lesen
04.10.23QIAGEN N.V.: QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virus316Venlo, the Netherlands, Oct. 04, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay. Epstein-Barr...
► Artikel lesen
04.10.23Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023290EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines, today announced...
► Artikel lesen
04.10.23TC Energy Corporation: TC Energy successfully completes $5.3 billion sale of a 40 per cent non-controlling equity interest in Columbia Gas and Columbia Gulf221CALGARY, Alberta, Oct. 04, 2023 (GLOBE NEWSWIRE) -- News Release - TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) today announced that it has successfully completed the sale of...
► Artikel lesen
04.10.23Accolade, Inc.: Accolade Announces Results for Fiscal Second Quarter 2024190SEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2023. "We are halfway through the 2024 fiscal...
► Artikel lesen
04.10.23ESGL Holdings Limited Reports First Half 2023 Results2121H revenues increase by 14.1% to $3.4 million on higher treatment volumes 1H +6.3% gross margin expansion from 58.4% to 64.7% Company updates guidance for 2023, expects to show positive Non-GAAP...
► Artikel lesen
04.10.23MaxCyte, Inc: MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance242ROCKVILLE, Md., Oct. 04, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery...
► Artikel lesen
04.10.23Zynerba Pharmaceuticals, Inc.: Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Biosciences Transaction: Process and Instructions669DEVON, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric...
► Artikel lesen
04.10.23IR-Med, Inc.: IR-MED Appoints Healthcare Executive and Entrepreneur Tzur Di-Cori as Chief Executive Officer98Mr. Di-Cori's vast healthcare experience includes President of LifeWatch Technologies, a developer of technologies that help physicians detect symptoms before they become major health problems Rosh...
► Artikel lesen
04.10.23Kronos Bio, Inc.: Kronos Bio To Present Interim Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at AACR-NCI-EORTC and Host Virtual Investor Event on October 13208SAN MATEO, Calif., and CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced...
► Artikel lesen
04.10.23Genasys Inc.: Genasys Completes Acquisition of Evertel199SAN DIEGO, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Genasys Inc. (NASDAQ: GNSS), the global leader in protective communications systems and solutions, today announced that it has completed the acquisition...
► Artikel lesen
Seite:  Weiter >>